In the evolving field of biochemical research, investigators often explore various c Cabergoline ompounds to understand hormonal regulation and receptor sensitivity. One such compound frequently discussed within research circles is peptides cabergoline. While often categorized alongside specialized research compounds, it is essential to clarify that this substance is a dopaminergic medication known primarily for its high affinity for specific receptors.
The Biochemical Profile of Cabergoline
From a research perspective, Cabergoline is recognized as a potent, long-acting dopamine receptor agonist. Specifically, Cabergoline is a selective D2-like dopamine receptor agonist that exhibits high binding affinity for D2, D3, a Amazon Pharmacy: CABERGOLINE 0.5 MG TAB nd 5-HT2B receptors. With a CAS number of 81409-90-7, this ergot-derived compound is often utilized in endocrine studies.
When evaluating high-purity Cabergoline, researchers often look for verification via NMR and HPLC analysis to ensure the integrity of the substance. Because Cabergoline is a dopamine receptor agonist, it is frequently studied for its ability to interact with the pituitary gland. Its primary mechanism involves preventing prolactin from being released by the pituitary gland, which is a focal point for those studying endocrine signaling pathways.
Research Context and Observations
In laboratory settings, Cabergoline is a synthetic liquid—or sometimes delivered in tablet form—that has been subject to extensive study since its discovery in 1981. Many investigators use this compound to explore how Cabergoline decreases the production of prolactin, a hormone that controls various physiological functions.
In the context of hormone regulation, is used to treat hyperprolactinemia in experimental models, as it acts as an effective long-acting dopamine agonist and prolactin inhibitor. While some sources discuss Cabergoline (Dostinex) treats high levels of prolactin, it is important to distinguish between clinical applications and the basic research protocols where scientists might utilize Cabergoline (CAB to observe receptor modulation.
Practical Considerations for Researchers
When sourcing materials for study, professionals often encounter options such as Cabergoline 0.5mg x 30ml or Cabergoline 0.5mg per ml x 30ml solutions. These sterile preparations are intended for research environments. Whether one is sourcing a Cabergoline Tablet 0.5 mg or a liquid variant, the focus remains on by E Ciccarelli·1989·Cited by 104—Cabergoline (CAB) is a new oral dopaminergic compound showing a very long-lasting PRL-lowering activity and reported to be well tolerated.Read more the compound’s ability to act as a selective D 2 -like dopamine receptor agonist.
It is noted in literature t Prolactin-releasing Peptide (PrRP) increases prolactin responses to hat Cabergoline is an ergot derived-dopamine D2-like receptor agonist, which differentiates it from other research peptides. While the term Special Offer Cabergoline 0.5mg x 30ml. Special Price .99 Regular Price .29. Add to Cart. Chat with us, powered by LiveChat. Close. Sign in. Don't have Read more peptide is often associated with these studies, it is Cabergoline | Dopamine Receptor agonist | CAS 81409-90-7 crucial to note that Hyperprolactinemia. Indicated for hyperprolactinemic disorders of either idiopathic or pituitary adenoma origin. Initital: 0.25 mg PO 2x/week.Read more Cabergoline itself is a small molecule, though it is frequently grouped in the same research catalogs as various peptides.
Safety and Handling
For those managing laboratory inventories, maintaining the purity of CABERGOLINE is vital. Researchers must be aware that while it can be used to treat certain menstrual problems, fertility problems in men and women in clinical Effectiveness and tolerability of long term treatment with settings, its primary role in the lab is to provide a controlled environment for observing dopamine-mediated responses.
As a dopaminergic medication used in the treatment of high prolactin levels, its potency requires precise handling. The recommended therapeutic dose: 2-3 mg daily is a clinical figure often cited in reference to historical data, but researchers should always consult institutional guidelines regarding the handling of Cabergoline Dostinex and similar compounds.
Conclusion
The study of hormone-modulating compounds remains a cornerstone of modern endocrine research. Whether investigating the nuances of is a tablet treatment used to reduce the production of a hormone called prolactin or analyzing the receptor affinity of this specific agonist, clear data and high-quality materials are essential. By understanding the chemical properties of this substance, researchers can continue to explore the complex interactions within the endocrine system safely and effectively.